top of page
Who We Are
The Company
Luciole is a start-up company focusing on the discovery and development of small molecules that accelerate the repair of oxidative damage to mitochondrial DNA (mtDNA). The company has combined decades of expertise in mitochondrial function, drug discovery and development, and use of the virtual company model to become the leader in correcting oxidative damage to mtDNA.
Luciole is applying cutting edge science to enhance the functionality of OGG1 (8-oxoguanine DNA glycosylase), the key enzyme in the initiation of base excision repair (BER) of mtDNA.
The Management Team
Dennis Goldberg, PhD
President and CEO, Director, Co-founder
Bill Rumsey, PhD
Vice President and CSO, Director, Co-founder
Eric Morrel, PhD
Vice President and COO, Director, Co-founder
![Donald-114[2305843009229551444] (2)_edited.jpg](https://static.wixstatic.com/media/367d24_cf454e3881ed4203bb71c991e10378b1~mv2.jpg/v1/fill/w_110,h_121,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/Donald-114%5B2305843009229551444%5D%20(2)_edited.jpg)
Director
Scientific Advisors
Co-founder
Professor, Molecular and Medical Genetics, School of Medicine, Oregon Health and Science University
Co-founder
Professor, Molecular and Medical Genetics, School of Medicine,
Oregon Health and Science University
Page and William Black Professor of Neurology
Chief, Division of Movement Disorders
Columbia University Irving Medical Center
Anchor 1
.jpg)
Ralph A. Rivero, PhD
Medicinal Chemist
Professor of Medicine, University of Minnesota
Jonathan Q. Purnell, MD
Professor of Medicine, Division of Cardiovascular Medicine
Oregon Health & Science University
bottom of page